AORT
Artivion Inc
NYSE: AORT · HEALTHCARE · MEDICAL DEVICES
$34.64
-4.65% today
Updated 2026-04-29
Market cap
$1.68B
P/E ratio
164.95
P/S ratio
3.81x
EPS (TTM)
$0.21
Dividend yield
—
52W range
$23 – $48
Volume
0.4M
Artivion Inc (AORT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$34.64
12-Month target
$1.43
2030 Target
—
Intrinsic (DCF)
$35.30
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.4B | $0.4B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 2.21%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.